Symptoms of anxiety and depression associated with steroid efficacy and clinical outcomes in patients with inflammatory bowel disease [PDF]
BackgroundAnxiety and depression symptoms are very common in patients with inflammatory bowel disease (IBD). We aimed to explore the impact of anxiety and depression on the efficacy of medications, as well as IBD-related poor outcomes.MethodThis was a ...
Shihao Duan+5 more
doaj +3 more sources
Animal models sensitive to anti‐anxiety agents [PDF]
Animal models of anxiety serve two primary purposes in psycho‐pharmacological research. (i) The pharmacological profile observed in the model provides a basis which, depending on its predictive validity, permits an estimation of clinical activity. (ii) Insofar as the ‘anxiety’ occurring in the animal model is homologous to human anxiety disorders, it ...
Peter R. Martin
openalex +4 more sources
Evaluation of Depression and Anxiety Disorders and Correlation with the Treatment of Patients with Psoriasis Vulgaris [PDF]
Introduction: Psoriasis is a chronic inflammatory multisystemic disease with several comorbidities, namely anxiety and depression disorders. Methods: In this study, the prevalence of these psychiatric entities was investigated by the PHQ-9 and GAD-7 ...
Adriana Kamilly Leitão Pitman Machado+4 more
doaj +3 more sources
Benzodiazepine anti-anxiety agents: prevalence and correlates of use in a southern community. [PDF]
BACKGROUND: Benzodiazepine anti-anxiety agents are the most widely prescribed psychotherapeutic drugs in the United States today. Recent evidence, however, suggests that their use may be decreasing. METHODS: We examine the population prevalence and correlates of use of benzodiazepine anxiolytics at the Duke site of the NIMH-sponsored Epidemiologic ...
M S Swartz+5 more
openalex +4 more sources
Synthesis and neuropharmacological evaluation of some new isoxazoline derivatives as antidepressant and anti-anxiety agents [PDF]
A series of 3-(furan-2-yl)-5-(substituted phenyl)-4,5-dihydro-1,2-oxazole derivatives (2a to j) were synthesized by Claisen Schmidt condensation of 2-acetyl furan with different types of aromatic aldehyde, as chalcones and their subsequent cyclization to 4,5-dihydro-1,2-oxazole with hydroxylamine hydrochloride.
Jagdish Kumar
openalex +4 more sources
Etizolam, an anti-anxiety agent which is an antagonist of platelet-activating factor receptors, was administered to patients with chronic subdural hematoma (CSH) after hematoma removal to assess the effectiveness for preventing recurrence compared with control patients not given the drug after surgery.
Yutaka Hirashima+4 more
openalex +5 more sources
An update on the pharmacological treatment of anxiety and related disorders [PDF]
The anxiety disorders, obsessive compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are common and debilitating, often coexist with medical and psychiatric conditions, and usually require long-term treatment.
K. Outhoff
doaj +3 more sources
Comparison of Effects of Glucagon-Like Peptide-1 Receptor Agonists Compared to Long-Acting Insulin, Added to Oral Anti-Diabetic Agents on Self-Management Behaviors, Anxiety, and Sleep Quality in Patients with Type 2 Diabetes. [PDF]
Song X+5 more
europepmc +2 more sources
A Survey of Anti-Anxiety Agents Used Over the Past 30 Years
Herman A. Dickel
openalex +4 more sources
Prescribing pattern of benzodiazepines in outpatients without a diagnosis of mental disorders: Retrospective study [PDF]
Introduction: Benzodiazepines (BZD) are efficient drugs used to reduce anxiety, treat insomnia, or used as myorelaxants. BZDs are generally recommended for short-term use due to numerous side-effects and addiction.
Stanetić Kosana D.+7 more
doaj +1 more source